Galapagos NV & ASINEX Ltd. Initiate Drug Discovery Collaboration in Bone and Joint Diseases
May 12, 2005 02:12 ET
|
Crucell N.V.
MECHELEN, Belgium and MOSCOW, May 12, 2005 (PRIMEZONE) -- Galapagos NV, a genomics-based drug discovery company and ASINEX Ltd, a worldwide leader in lead generation and optimization announce that...
Crucell N.V.: Single-Shot Outbreak Vaccine Provides Full Protection Against Ebola According to Results of New Animal Studies
April 29, 2005 02:09 ET
|
Crucell N.V.
LEIDEN, Netherlands, April 29, 2005 (PRIMEZONE) -- Dutch biotechnology company Crucell N.V. (Euronext:CRXL) (Nasdaq:CRXL) today reported new results from its Ebola vaccine studies. The studies,...
Crucell to Present at Rodman & Renshaw 2nd Annual Global Healthcare Conference, May 4
April 27, 2005 02:06 ET
|
Crucell N.V.
LEIDEN, Netherlands, April 27, 2005 (PRIMEZONE) -- Dutch biotechnology company Crucell N.V. (Euronext:CRXL) (Nasdaq:CRXL) today announced that its Chief Financial Officer, Leonard Kruimer CPA, will...
Crucell Announces First Quarter 2005 Results
April 18, 2005 08:38 ET
|
Crucell N.V.
-- Agreements signed for further development and
commercialization of Ebola and Marburg vaccines.
-- Strong US and European endorsement of PER.C6(R)-based
vaccine technology.
-- Five new...
Crucell and NIH Sign 21.4 Million Ebola Vaccine Manufacturing Contract
April 14, 2005 02:17 ET
|
Crucell N.V.
LEIDEN, Netherlands, April 14, 2005 (PRIMEZONE) -- Dutch biotechnology company Crucell N.V. (Euronext:CRXL) (Nasdaq:CRXL) announced today that it has signed a manufacturing contract with the Vaccine...
Cystic Fibrosis Foundation Therapeutics and Galapagos Initiate
April 14, 2005 01:31 ET
|
Crucell N.V.
BETHESEDA, Maryland and LEIDEN, Netherlands, April 14, 2005 (PRIMEZONE) -- Galapagos and Cystic Fibrosis Foundation Therapeutics Sign Euro 1.3 million* Agreement.
Cystic Fibrosis Foundation...
Galapagos Appoints Andre Hoekema as Managing Director Galadeno
April 12, 2005 05:07 ET
|
Crucell N.V.
LEIDEN, Netherlands, April 12, 2005 (PRIMEZONE) -- Galapagos, a genomics-based drug discovery company, has appointed Dr. Andre Hoekema as Managing Director of Galadeno, Galapagos' services unit....
Crucell to Release First Quarter 2005 Earnings on Monday, April 18
April 05, 2005 08:07 ET
|
Crucell N.V.
LEIDEN, Netherlands, April 05, 2005 (PRIMEZONE) -- Dutch biotechnology company Crucell N.V. (Euronext:CRXL) (Nasdaq:CRXL) today announced that it will release its financial results for the first...
Crucell Receives U.S. Patent Covering its STAR Technology
April 05, 2005 02:07 ET
|
Crucell N.V.
LEIDEN, Netherlands, April 5, 2005 (PRIMEZONE) -- Dutch biotechnology company Crucell N.V. (Euronext:CRXL) (Nasdaq:CRXL) announced today that it has been granted a patent by the United States Patent...
Crucell's Cell-Culture Technology to Be Part of Major U.S. Government Influenza Pandemic Vaccine Program
April 01, 2005 10:44 ET
|
Crucell N.V.
LEIDEN, Netherlands, April 1, 2005 (PRIMEZONE) -- Dutch biotechnology company Crucell N.V. (Euronext:CRXL) (Nasdaq:CRXL) announced today that its partner sanofi pasteur, the vaccines business of the...